Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2001 1
2007 3
2008 1
2010 3
2011 2
2012 2
2013 2
2014 4
2015 3
2017 6
2018 2
2019 1
2020 2
2021 6
2022 5
2023 7
2024 7
2025 7
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Retraction notice.
[No authors listed] [No authors listed] J Health Psychol. 2021 Jan;26(1):181. doi: 10.1177/1359105316685949. Epub 2017 Feb 1. J Health Psychol. 2021. PMID: 28810412
At the request of the Journal Editor and the Publisher, the following article has been retracted: Khani Jeihooni A, Hidarnia A, Hossein Kaveh M, Hajizadeh E and Askari A (2015) The effect of an education program based on health belief model and social cognitive theo …
At the request of the Journal Editor and the Publisher, the following article has been retracted: Khani Jeihooni A, Hidarnia A, Hosse …
Re: Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder: E. Xylinas, E. K. Cha, F. Khani, L. A. Kluth, M. Rieken, B. G. Volkmer, R. Hautmann, R. Kufer, Y.-T. Chen, M. Zerbib, M. A. Rubin, D. S. Scherr, S. F. Shariat and B. D. Robinson J Urol 2014;191:830-841.
Szarvas T, Rübben H, Reis H. Szarvas T, et al. J Urol. 2014 Aug;192(2):617-8. doi: 10.1016/j.juro.2014.02.2571. Epub 2014 May 2. J Urol. 2014. PMID: 24792989 No abstract available.
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry.
Gheybi K, Soh PXY, Jiang J, Mbeki TMN, Louw M, Burns D, Mundra P, Kiriy D, Hasan MM, Jaratlerdsiri W, Lebelo MT, Campbell RA, Radzuma MB, Nenzhelele M, Obida M, Obida M, Ombuki WM, Oyaro MO, Patrick SM, Loda M, Wedge DC, Bristow RG, Brewer DS, Cooper CS, Reimand J, Cancel-Tassin G, Cussenot O, Hovens CM, Cocoran NM, Stricker PD, Schlomm T, Prins GS, Sørensen KD; Pan Prostate Cancer Group; HEROIC PCaPH Africa1K; Weischenfeldt J, Mutambirwa SBA, Ngugi PM, Thomas DM, Kote-Jarai Z, Eeles RA, Bornman MSR, Hayes VM. Gheybi K, et al. Nat Commun. 2025 Oct 2;16(1):8799. doi: 10.1038/s41467-025-63865-6. Nat Commun. 2025. PMID: 41038821 Free PMC article.
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis.
Ohara K, Rendeiro AF, Bhinder B, Eng KW, Ravichandran H, Nguyen D, Pisapia D, Vosoughi A, Fernandez E, Shohdy KS, Manohar J, Beg S, Wilkes D, Robinson BD, Khani F, Bareja R, Tagawa ST, Ouseph MM, Sboner A, Elemento O, Faltas BM, Mosquera JM. Ohara K, et al. Nat Commun. 2024 Mar 18;15(1):2009. doi: 10.1038/s41467-024-46320-w. Nat Commun. 2024. PMID: 38499531 Free PMC article.
Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations.
Akçimen F, Paquette K, Wild Crea P, Step K, Waldo E, Koretsky MJ, Saffie-Awad P, Achoru C, Taiwo F, Ozomma S, Onwuegbuzie G, Khani M, Grant S, Owolabi L, Okereke C, Oshinaike O, Iwuozo E, Akerman SC, Lee PS, Oyakhire S, Osemwegie N, Daida K, Abubakar S, Olusanya A, Isayan M, Alvarez C, Traurig R, Ogunmodede A, Samuel S, Makarious MB, Sa'ad F, Olanigan R, Levine K, Ogbimi EM, Vitale D, Odiase F, Ojini F, Odeniyi O, Fang ZH, Obianozie N, Hall DA, Nwazor E, Xie T, Nwaokorie F, Padmanaban M, Nwani P, Shamim EA, Nnama A, Standaert D, Komolafe M, Dean M, Osaigbovo G, Disbrow E, Ishola I, Rawls A, Imarhiagbe F, Chandra S, Erameh C, Hinson V, Louie N, Idowu A, Solle J, Norris SA, Ibrahim A, Kilbane C, Sukumar G, Shulman LM, Ezuduemoih D, Staisch J, Breaux S, Dalgard C, Foster ER, Bello A, Ameri A, Real R, Ikwenu E, Morris HR, Anyanwu R, Furr Stimming E, Billingsley K, Alaofin W, Alvarez Jerez P, Agabi O, Hernandez DG, Akinyemi R, Arepalli S, Malik L, Owolabi R, Nyandaiti Y, Leonard HL, Wahab K, Abiodun O, Hernandez CF, Abdulai F, Iwaki H, Bardien S, Klein C, Hardy J, Houlden H, Galvelis KG, Nalls MA, Dahodwala N, Aamodt W, Hill E, Espay A, Factor S, Branson C, Blauwendraat C, Singleton AB… See abstract for full author list ➔ Akçimen F, et al. Brain. 2026 May 5;149(5):1537-1553. doi: 10.1093/brain/awaf379. Brain. 2026. PMID: 41058593 Free PMC article.
Clinical and molecular significance of the RNA m(6)A methyltransferase complex in prostate cancer.
Lothion-Roy J, Haigh DB, Harris AE, Metzler VM, Alsaleem M, Toss MS, Kariri Y, Ntekim A, Robinson BD, Khani F, Gudas LJ, Allegrucci C, James VH, Madhusudan S, Mather M, Emes RD, Archer N, Fray RG, Rakha E, Jeyapalan JN, Rutland CS, Mongan NP, Woodcock CL. Lothion-Roy J, et al. Front Genet. 2023 Jan 12;13:1096071. doi: 10.3389/fgene.2022.1096071. eCollection 2022. Front Genet. 2023. PMID: 36733939 Free PMC article.
N(6)-methyladenosine (m(6)A) is the most abundant internal mRNA modification and is dynamically regulated through distinct protein complexes that methylate, demethylate, and/or interpret the m(6)A modification. These proteins, and the m(6)A modification, are …
N(6)-methyladenosine (m(6)A) is the most abundant internal mRNA modification and is dynamically regulated through distinct protein co …
fNIRS reproducibility varies with data quality, analysis pipelines, and researcher experience.
Yücel MA, Luke R, Mesquita RC, von Lühmann A, Mehler DMA, Lührs M, Gemignani J, Abdalmalak A, Albrecht F, de Almeida Ivo I, Artemenko C, Ashton K, Augustynowicz P, Bajracharya A, Bannier E, Barth B, Bayet L, Behrendt J, Khani HB, Borot L, Borrell JA, Brigadoi S, Brink K, Bulgarelli C, Caruyer E, Chen HC, Copeland C, Corouge I, Cutini S, Di Lorenzo R, Dresler T, Eggebrecht AT, Ehlis AC, Erdoğan SB, Evenblij D, Ferdous TR, Fracalossi V, Franzén E, Gallagher A, Gerloff C, Gervain J, Goldhamer N, Gossé LK, Guérin SMR, Guevara E, Hosseini SMH, Innes-Brown H, Int-Veen I, Jaffe-Dax S, Jégou N, Kawaguchi H, Kelsey C, Kent M, Kessler R, Kherbawy N, Klein F, Kochavi N, Kolisnyk M, Koren Y, Kroczek A, Kvist A, Lin CP, Löw A, Luan S, Mao D, Martins GG, Middell E, Montero-Hernandez S, Mutlu MC, Novi SL, Paquette N, Paranawithana I, Parmet Y, Peelle JE, Peng K, Peng T, Pereira J, Pinti P, Pollonini L, Jounghani AR, Reindl V, Ringels W, Schopp B, Schulte A, Schulte-Rüther M, Segel A, Ala TS, Shader MJ, Shavit H, Sherafati A, Soltanlou M, Sorger B, Speh E, Stubbs KD, Stute K, Sullivan EF, Tak S, Tipado Z, Tremblay J, Vahidi H, Van Eeckhoutte M, Vannasing P, Vergotte G, Vincent MA, Weiss E, Yang D… See abstract for full author list ➔ Yücel MA, et al. Commun Biol. 2025 Aug 4;8(1):1149. doi: 10.1038/s42003-025-08412-1. Commun Biol. 2025. PMID: 40760004 Free PMC article.
Bone Marrow Mesenchymal Stem Cells for Heart Failure Treatment: A Systematic Review and Meta-Analysis.
Kalou Y, Al-Khani AM, Haider KH. Kalou Y, et al. Heart Lung Circ. 2023 Jul;32(7):870-880. doi: 10.1016/j.hlc.2023.01.012. Epub 2023 Mar 3. Heart Lung Circ. 2023. PMID: 36872163
RESULTS: The pooled weighted mean difference (WMD) showed that BM-MSCs treatment improved the 6MWD by 27.86 m (95% CI 0.11-55.6 m) compared with the control groups. The pooled WMD showed that BM-MSCs treatment improved the LVEF by 6.37% (95% CI 5.48%-7.26%) compared …
RESULTS: The pooled weighted mean difference (WMD) showed that BM-MSCs treatment improved the 6MWD by 27.86 m (95% CI 0.11-55.6 m …
60 results